The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE: Commentary

Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)119-120
Number of pages2
JournalInternational Journal of Advances in Rheumatology
Volume8
Issue number3
StatePublished - Dec 1 2010

ASJC Scopus subject areas

  • Rheumatology

Cite this